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(annular diameter $ 40 mm) is present. When LV end-
diastolic diameter exceeds 65 mm, an external cardiac
constraint device (CorCap cardiac support device; Acorn
Cardiovascular, St Paul, Minn) is also applied. These patients
have a 6% operative mortality, and long-term results are
currently being evaluated. When LV end-diastolic dimension
exceeds 80 mm, surgical LV restoration is considered as
described by Isomura et al.11
The current results strengthen the hypothesis that grades 3
to 41 functional MR can be successfully treated by restric-
tive mitral annuloplasty in patients with LV dilatation but
relatively mild heart failure (NYHA class II to III). On a pa-
tient basis, 89% and 72% of patients exhibited a significant
reduction in LV volumes. These observations are clinically
relevant because LV function and volumes have been dem-
onstrated to be important predictors of long-term outcome
in patients with LV dysfunction.12,13 Also, LA dimensions
have been shown to provide prognostic information.14,15 In
the present study, LA volume in end systole showed a signif-
icant decrease, although LA volume in end diastole did not
exhibit a decrease in the entire study population.
On the basis of the reverse remodeling observed in the cur-
rent study, one could speculate that the point of no return
(irreversible LV dilatation) was not yet reached in this patient
category, suggesting that mitral valve surgery may be consid-
ered at an earlier stage in patients with nonischemic dilated
cardiomyopathy. Further prospective studies are needed to
confirm the benefit of early surgical intervention in patients
with mild heart failure.
Conclusions
MRI provides a powerful tool for the evaluation of the LV
and LA reverse remodeling process in patients with mild
heart failure with functional MR and nonischemic dilated
cardiomyopathy who underwent isolated restrictive annulo-
plasty. At late (3–4 years) follow-up, sustained significant
LV and LA reverse remodeling was demonstrated using
MRI. It should be emphasized that the current findings
have been obtained in a highly selected patient population
and that further MRI experience in patients with more
advanced stages of heart failure is needed.
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Dr Michael Acker (Philadelphia, Pa). I congratulate the authors
for this well-conducted study using what is considered by many
as the gold standard in looking at cardiac volumes. You confirmed
in your patients with moderate heart failure that by correcting MR
we can see reverse remodeling, which we have seen in many other
types of groups. I have 4 questions.
Mitral insufficiency and heart failure are often very dynamic, and
these patients were not that sick. Were these patients really opti-
mized on standard advanced medical therapy before you attempted
to operate? How long were they followed before making the deci-
sion to operate?
Dr Jerry Braun (Leiden, The Netherlands). All patients were on
a good medical treatment strategy. All patients had at least had di-
uretics.
Dr Acker. Were they all on beta-blockers and angiotensin-
converting enzyme inhibitors? If not, what percentage?
Dr Braun. All patients were receiving angiotensin-converting
enzyme inhibitors, and the majority were receiving beta-blockers
(80% or 90%), this was continued after surgery.
DrAcker. I saw that there was a bit of residual MR at your follow-
up (0.66), suggesting that some patients had up to 21MR. If you everne 2008
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CDdo see that, can you give us a hint on what preoperative characteristics
of the patients, the ventricle, or the actual mitral valve might indicate
late failure of your repair with a small annuloplasty ring?
Dr Braun. In this group, none of the patients had grade 2 MR.
We know from our studies in ischemic patients, after 4 years about
85% has no grade 2 MR, while 15% has. In that patient group we
tried to relate it to preoperative variables, but were not able to find
a relation. It occurs both in the larger ventricle group as well as in
the smaller ventricle group.
Dr Acker. Nothing about the degree of coaptation depth or
annular size or whether it’s an eccentric jet or central jet would
indicate?
Dr Braun. No, not at all.
Dr Acker. Two of your patients died. At death—I don’t know if
they were censored from your results or not—did they have return of
MR and did you see a lack of reverse remodeling in these 2 patients
who died of progressive heart failure?
Dr Braun. Two patients died. One patient died several months
after surgery, suddenly, probably because of ventricular arrhyth-
mias. The other died shortly after emergent surgery for a vascular
problem. The last echo several months before death showed a com-
petent mitral valve and no progression of LV dilatation.
Dr Acker. You’ve demonstrated that there is reverse modeling
in moderate heart failure. Do you have any evidence that you can
share with us for patients with advanced heart failure secondary to
idiopathic myopathy, such as these, and for patients with ischemic
cardiomyopathy?The Journal of ThorDr Braun. We’re working on our complete series of nonische-
mic patients. Unfortunately, we’re not able to follow them with
MRI, but with echocardiography. We’re still working on that.
I should say that currently we treat these patients with the CorCap
cardiac support device (Acorn Cardiovascular; St. Paul, Minn,
USA) device if they have an LV end-diastolic dimension exceeding
65 mm; we don’t only do a restrictive mitral annuloplasty.
I should say that we treat these patients currently, if they have
a left ventricular end diastolic dimension exceeding 65 mm, not
only by a restrictive mitral annuloplasty, but we also add a CorCap
cardiac support device (Acorn Cardiovascular; St. Paul, Minn,
USA). In the ischemic patients, that we presented at the STS meeting
in San Diego earlier this year we obtained results that are quite
promising, as I said. Maybe I can show a discussion slide.
Dr Starnes. I don’t think we have time.
Dr Braun. The results are very promising.
Dr Hormoz Azar (Norfolk, Va). There will be a certain amount
of remodeling just by inserting the ring. Did you measure the mid-
ventricular diameter and did that show diminution in time, or how
much of it was related just to cinching the ventricle by the ring?
Dr Braun. Of course, that difference is difficult to make. We
measured the volumes in this series, so we get an overall impression
of the ventricle. By echocardiography, we measure the end-diastolic
dimension at the level where the tips of the mitral leaflets close, or at
least where the tips of the papillary muscles are located, and we see
a decrease at that level as well. But that is not a way to discern
whether this is why MR is observed.acic and Cardiovascular Surgery c Volume 135, Number 6 1253
